Screener
Rigel Pharmaceuticals RIGL Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $60.87M+13.9% | $24.47M-46.6% | $40.64M-28.4% | $48.53M-6.1% | $53.46M+48.3% | ||
| $34.51M-37.2% | $122.27M+290% | $114.38M+456% | $88.61M+840% | $54.97M+321% | ||
| $56.04M+40.4% | $49.95M+20.2% | $51.76M+24.4% | $45.93M+50.2% | $39.91M+38.1% | ||
| $14.37M+37.8% | $11.65M+150% | $11.51M+91.7% | $13.3M+178% | $10.42M+29.3% | ||
| $185.53M+5.8% | $234.03M+59.7% | $240.17M+77.8% | $214.93M+102% | $175.39M+85.2% | ||
| $93.88M+262% | $24.16M-8.9% | $24.75M-8.7% | $25.34M-8.5% | $25.92M-8.3% | ||
| $93.88M— | $24.16M— | $24.75M-8.7% | —— | —— | ||
| $521.07M+152% | $504.61M+187% | $513.59M+213% | $242.53M+74.0% | $206.74M+61.0% | ||
| $4.01M-45.0% | $4.49M+13.5% | $7.19M+115% | $3.85M+0.8% | $7.29M+18.9% | ||
| $95.59M+10.3% | $89.49M+34.3% | $99.24M+56.8% | $94.4M+73.8% | $86.64M+47.7% | ||
| $40M— | $45M— | $52.5M— | —— | —— | ||
| $95.64M-23.4% | $104.71M-33.5% | $122.11M-24.0% | $124.93M-18.9% | $124.8M-21.2% | ||
| $18K0.0% | $18K0.0% | $18K-100.0% | $18K+5.9% | $18K+5.9% | ||
| -$997.1M+24.4% | -$1.01B+26.4% | -$1.02B+26.4% | -$1.29B+8.1% | -$1.32B+6.9% | ||
| $425.42M+419% | $399.9M+2,054% | $391.48M+11,806% | $117.61M+904% | $81.93M+374% | ||
| $521.07M+152% | $504.61M+187% | $513.59M+213% | $242.53M+74.0% | $206.74M+61.0% |
FAQ
- What are Rigel Pharmaceuticals's total assets?
- Rigel Pharmaceuticals (RIGL) holds $521.1M in total assets, up 152.0% year over year.
- How much debt does Rigel Pharmaceuticals have?
- Rigel Pharmaceuticals carries $40.7M in total debt against $425.4M of shareholders' equity, a debt-to-equity ratio of 0.10.
- How much cash does Rigel Pharmaceuticals have?
- Rigel Pharmaceuticals holds $60.9M in cash and equivalents.
- Can Rigel Pharmaceuticals cover its short-term obligations?
- Its current ratio is 1.94 — current assets exceed current liabilities.
- Where does Rigel Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Rigel Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
